$638 Million is the total value of Newman Dignan & Sheerar, Inc.'s 186 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| INDB | New | Independent Bank Corp Ma | $346,000 | – | 4,637 | +100.0% | 0.05% | – |
| IBDR | New | iShares iBonds Dec 2026 Corp Bd ETFetf | $254,000 | – | 10,977 | +100.0% | 0.04% | – |
| TSLA | New | Tesla Motors Inc | $228,000 | – | 861 | +100.0% | 0.04% | – |
| New | Ashford Hospitality Trust Inc | $111,000 | – | 16,332 | +100.0% | 0.02% | – | |
| OR | New | Osisko Gold Royaltie | $108,000 | – | 10,639 | +100.0% | 0.02% | – |
| OVID | New | Ovid Therapeutics Inc | $29,000 | – | 15,522 | +100.0% | 0.01% | – |
| CLSD | New | Clearside Biomedical Inc | $31,000 | – | 27,023 | +100.0% | 0.01% | – |
| ONCY | New | Oncolytics Biotech | $16,000 | – | 12,915 | +100.0% | 0.00% | – |
| TCRR | New | TCR2 Therapeutics Inc | $21,000 | – | 11,522 | +100.0% | 0.00% | – |
| MDNA | New | Medicenna Therapeutics Corp | $11,000 | – | 12,915 | +100.0% | 0.00% | – |
| New | MIRION TECHNOLOG | $15,000 | – | 10,023 | +100.0% | 0.00% | – | |
| New | Aptose Biosciences | $11,000 | – | 18,915 | +100.0% | 0.00% | – | |
| SLDB | New | Solid Biosciences Inc | $7,000 | – | 15,023 | +100.0% | 0.00% | – |
| New | Document Security Systems Inc | $4,000 | – | 15,523 | +100.0% | 0.00% | – | |
| OGEN | New | Oragenics Inc | $2,000 | – | 10,468 | +100.0% | 0.00% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-10-18
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Schwab Dow Jones US Div Eq ETF | 42 | Q3 2023 | 6.6% |
| Schwab Dow Jones US Large Cap ETF | 42 | Q3 2023 | 7.3% |
| Schwab Dow Jones US Large Growth ETF | 42 | Q3 2023 | 4.9% |
| Schwab Dow Jones US Large Value ETF | 42 | Q3 2023 | 4.5% |
| Apple, Inc | 42 | Q3 2023 | 20.8% |
| Schwab Dow Jones US Sm-Cap ETF | 42 | Q3 2023 | 13.5% |
| Microsoft Corp | 42 | Q3 2023 | 3.4% |
| Johnson & Johnson | 42 | Q3 2023 | 2.9% |
| Novartis A G | 42 | Q3 2023 | 56.8% |
| Merck & Co Inc | 42 | Q3 2023 | 2.5% |
View Newman Dignan & Sheerar, Inc.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-04-29 |
| 13F-HR | 2024-02-09 |
| 13F-HR | 2023-11-08 |
| 13F-HR | 2023-08-02 |
| 13F-HR | 2023-04-28 |
| 13F-HR | 2023-01-20 |
| 13F-HR | 2022-10-18 |
| 13F-HR | 2022-08-03 |
| 13F-HR | 2022-04-14 |
| 13F-HR | 2022-01-18 |
View Newman Dignan & Sheerar, Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.